Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Phase 1a: First-in-Human Single Ascending Dose Study (NCT02951806) Study Title: "Safety, Tolerability, and Pharmacokinetics of Single Doses of Cagrilintide in Healthy Subjects" Status: Completed Phase: Phase 1a Enrollment: 48 healthy volunteers Study Period: 2016-2017 Location: Single center (Denmark) Design: Randomized, double-blind, placebo-controlled, single ascending dose Dose Range: 0.03-10 mg SC Primary Endpoints: Safety, tolerability, PK parameters Population: Healthy male subjects, BMI 20-28 Key Results: Pharmacokinetics: Terminal half-life 5-7 days across dose range
However, there are to date no clinical studies that have examined neuroprotective effects of neither endogenous nor pharmacologically administered GLP-1 in mitigating the impact of a stroke in humans [20]
IN-VITRO RESEARCH ONLY NOT FOR HUMAN USE TM Bacteriostatic Water Product information $25.00 Product description This premium bacteriostatic water is a sterile, high-purity formulation manufactured in a U.S.-based, GMP-compliant facility, designed exclusively for laboratory research applications.This advanced solution meets the exacting standards required for peptide and protein reconstitution in scientific studies
These studies have similarly shown no significant increase in thyroid cancer rates compared to the general population
Importantly, current literature does not thoroughly explore the relationship between treatment duration and propensity for weight regain
A distinguishing safety point in ipamorelin's favor is its selectivity : unlike older GHRPs, it was characterized as not meaningfully raising cortisol or prolactin, which reduces one category of hormonal side effect
US$ 23.88
US$ 24.35
US$ 24.59
US$ 25.13
US$ 28.57
